Distinguished Scientist, Pharmacokinetics

Merck•Boston, MA
•$210,400 - $331,100•Hybrid

About The Position

The Department of Pharmacokinetics, Dynamics, Metabolism and Bioanalytics (PDMB) is seeking a Distinguished Scientist to serve as a Drug Metabolism and Pharmacokinetics (DMPK) submission expert. The role supports the development pipeline by ensuring high-quality nonclinical pharmacokinetics submissions from first-in-human studies through marketing applications and lifecycle management. The scientist will contribute to PDMB portfolio support strategy and DMPK priorities across therapeutic areas and modalities, ensuring submission packages are robust and aligned with program objectives. The role involves assessing drug disposition in the context of benefit-risk, drug interaction potential, target populations, and regulatory guidelines. The Distinguished Scientist will influence portfolio decisions and contribute to regulatory filings, labeling discussions, and approvals. As a member of the DMPK Leadership team, the role contributes to global scientific and portfolio strategy and talent development, while demonstrating strong ethics, negotiation skills, exemplary ways of working, and an enterprise mindset. The position is based primarily in West Point, Pennsylvania, with a hybrid work arrangement, 10% travel, and a day shift. Relocation assistance is available domestically and internationally, and visa sponsorship is offered.

Requirements

  • PhD or M.Sci. in Pharmaceutical Sciences, Pharmacology, or a related field.
  • At least 15 years of experience in DMPK, including extensive experience as a team representative in drug discovery and development programs.
  • Strong scientific acumen and understanding of drug development processes and relevant regulatory guidelines, with a track record supporting clinical candidates and first-in-human execution.
  • Experience collaborating with and mentoring program team representatives on nonclinical and clinical issues.
  • Strong leadership skills and ability to collaborate with and influence scientists across scientific disciplines and strategic directions.
  • Efficient organizational skills and excellent verbal and written communication skills, including the ability to develop and deliver clear, concise documents and presentations.
  • Experience authoring and critically reviewing nonclinical PK packages and clinical sections of regulatory documents, including IBs, INDs, CTAs, NDAs, BLAs, MAAs, PIP/PSPs, Scientific Advice, weight-of-evidence risk assessments, regulatory responses, and product labels.
  • Demonstrated experience navigating issues and regulatory requirements for advancing drug development candidates across modalities from preclinical development through Phase 4, regulatory approvals, and/or post-approval commitments.
  • Required skills include drug development, drug metabolism, pharmacokinetics, portfolio strategies, regulatory filings, regulatory strategies, regulatory submissions, scientific leadership, and small molecules.

Nice To Haves

  • Extensive experience in early development and product development teams.
  • Experience in Scientific Advisory Committee meetings with the FDA and/or other regulatory agencies.
  • Deep understanding of filing and labeling requirements across major world markets.

Responsibilities

  • Monitor late-stage development and post-marketing programs to ensure nonclinical packages for original marketing applications and supplemental applications are robust, timely, aligned with filing strategy, and consistent with clinical safety and efficacy positions.
  • Represent PDMB on Label Approval Strategy Teams and in discussions requiring DMPK expertise, including clinical safety and risk management, nonclinical safety mechanistic investigations, ICH guidance, and label updates.
  • Review investigator brochures, clinical trial applications, INDs, NDAs, regulatory responses, and other legal or scientific documents supporting global clinical trials and registration.
  • Provide scientific and strategic oversight for development candidates across therapeutic areas, collaborating with PDMB representatives, subject-matter experts, management, and functional partners to align regulatory strategy and mechanistic investigation input.
  • Contribute to Clinical Pharmacology strategy, including starting dose, dose escalation, timing, design, and interpretation of Phase 1 studies, such as drug interaction, special population, and human ADME studies, using nonclinical data generated by PDMB.
  • Ensure DMPK data and documentation practices maintain quality as regulatory expectations change across countries and regions.
  • Lead internal and cross-departmental initiatives to improve policies, procedures, and strategic direction in line with portfolio strategy and regulatory expectations.
  • Oversee and/or conduct critical due diligence reviews for in-licensing assets across therapeutic areas and serve as integration lead.
  • Serve as program representative for high-priority development programs.
  • Contribute to developing future leaders in drug development, regulatory processes, risk assessments, and regulatory guidelines.

Benefits

  • Medical, dental, and vision healthcare benefits and other insurance benefits for employees and family.
  • Retirement benefits, including 401(k).
  • Paid holidays, vacation, compassionate days, and sick days.
  • Annual bonus and long-term incentive, if applicable.
  • Domestic and international relocation.

Stand Out From the Crowd

Upload your resume and get instant feedback on how well it matches this job.

Upload and Match Resume

What This Job Offers

Job Type

Full-time

Career Level

Senior

Education Level

Ph.D. or professional degree

© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service